Hvivo (HVO)

Sector:

Health Care

Index:

FTSE AIM All-Share

28.50p
   
  • Change Today:
      0.60p
  • 52 Week High: 30.60
  • 52 Week Low: 18.00
  • Currency: UK Pounds
  • Shares Issued: 680.37m
  • Volume: 1,724,303
  • Market Cap: £193.91m

Open Orphan secures €900,000 contract with existing customer

By Iain Gilbert

Date: Wednesday 14 Jul 2021

LONDON (ShareCast) - (Sharecast News) - Pharmaceutical services company Open Orphan has secured a new contract win with an unnamed existing customer.
Open Orphan said on Wednesday that the new contract would be worth roughly €900,000 to the company and would see it undertake clinical trial management for the client at its Breda, Netherlands office.

Chairman Cathal Friel said: "This new contract win demonstrates the ongoing and continued success of our Breda office which continues to sign multiple contracts and only those close to £1.0m and above are announced.

"Our Breda office is getting more and more integrated with our London business, and the entire Open Orphan group is excelling as the global leader in the testing of vaccines, anti-virals and other infectious disease therapeutics."

Separately, Open Orphan said its hVIVO subsidiary was continuing to work with the UK Government in order to inoculate up to 20 further volunteers as part of the world's first Covid-19 characterisation study.

As part of the characterisation study, researchers aim to identify a dose of Covid-19 that causes "a safe and reliable infection" in unvaccinated volunteers, with the study expansion due to commence as soon as "appropriate regulatory approvals and clinical preparations" were complete.

Revenue from the contract was also expected to be recognised in the current financial year.

As of 0910 BST, Open Orphan shares were up 4.75% at 26.45p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Hvivo Market Data

Currency UK Pounds
Share Price 28.50p
Change Today 0.60p
% Change 2.15 %
52 Week High 30.60
52 Week Low 18.00
Volume 1,724,303
Shares Issued 680.37m
Market Cap £193.91m

Hvivo Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.74% below the market average95.74% below the market average95.74% below the market average95.74% below the market average95.74% below the market average
65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average
Price Trend
78.19% above the market average78.19% above the market average78.19% above the market average78.19% above the market average78.19% above the market average
94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average
Income
94.38% below the market average94.38% below the market average94.38% below the market average94.38% below the market average94.38% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
52.34% above the market average52.34% above the market average52.34% above the market average52.34% above the market average52.34% above the market average
72.22% above the sector average72.22% above the sector average72.22% above the sector average72.22% above the sector average72.22% above the sector average

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 6
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Hvivo Dividends

  Latest Previous
  Final Special
Ex-Div 18-Apr-24 04-May-23
Paid 20-May-24 09-Jun-23
Amount 0.20p 0.45p

Trades for 31-Oct-2024

Time Volume / Share Price
16:37 275 @ 28.50p
16:20 71,610 @ 28.25p
16:16 7,150 @ 28.40p
15:56 3,469 @ 28.65p
14:48 150,000 @ 28.15p

Hvivo Key Personnel

CEO Yamin Mo' Khan

Top of Page